Legend Biotech Corporation Aktie
WKN DE: A2P5AH / ISIN: US52490G1022
13.05.2025 13:11:22
|
Legend Biotech Corporation Q1 Loss Rises
(RTTNews) - Legend Biotech Corporation (LEGN) released Loss for its first quarter of -$100.92 million
The company's earnings came in at -$100.92 million, or -$0.27 per share. This compares with -$59.79 million, or -$0.16 per share, last year.
Excluding items, Legend Biotech Corporation reported adjusted earnings of -$27.00 million or -$0.07 per share for the period.
The company's revenue for the period rose 107.5% to $195.05 million from $93.99 million last year.
Legend Biotech Corporation earnings at a glance (GAAP) :
-Earnings: -$100.92 Mln. vs. -$59.79 Mln. last year. -EPS: -$0.27 vs. -$0.16 last year. -Revenue: $195.05 Mln vs. $93.99 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Legend Biotech Corporation (spons. ADRs)mehr Nachrichten
12.05.25 |
Ausblick: Legend Biotech stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
10.03.25 |
Ausblick: Legend Biotech legt Quartalsergebnis vor (finanzen.net) |
Analysen zu Legend Biotech Corporation (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Legend Biotech Corporation (spons. ADRs) | 25,40 | 2,42% |
|